Is screening immigrants for latent tuberculosis cost-effective?

Lancet Infect Dis. 2011 Jun;11(6):418-9. doi: 10.1016/S1473-3099(11)70102-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Emigrants and Immigrants*
  • Humans
  • Latent Tuberculosis / blood
  • Latent Tuberculosis / diagnosis*
  • Latent Tuberculosis / economics
  • Mass Screening / economics
  • Mass Screening / methods
  • United Kingdom